How to perform safe anesthesia in patients with end-stage renal disease by Seidl, Christian Andreas & Eberle, Balthasar
Dialysis Access Creation
Widmer MK, Malik J (eds): Patient Safety in Dialysis Access.
Contrib Nephrol. Basel, Karger, 2015, vol 184, pp 107–122
DOI: 10.1159/000367905
 Abstract 
 Vascular surgical patients and especially those with end-stage renal disease are exposed 
to a high risk of preventable adverse events. Typically, a combination of organizational 
and technical deficiencies, human error or ineptitude and patient comorbidity leads to 
inadvertently poor outcome. Patient safety in perioperative environments requires per-
manent effort in organizational improvement, staff training, and maintenance of high 
standards in patient care and technical equipment. Even in multimorbid patients, anes-
thesia for vascular access surgery can be performed at low to moderate risk if safety prob-
lems are minimized.  © 2015 S. Karger AG, Basel 
 Recommendations to Improve Patient Safety 
  • Preoperative preparation for anesthesia should identify individual risks and 
areas for optimization. An interdisciplinary perioperative plan should be 
developed and communicated to the entire team.  
  • Institutionalized surgical safety checks and OR safety precautions help to 
reduce and manage unexpected adverse events. 
  • Locoregional anesthesia offers, as an advantage, transient regional sympa-
thectomy and blood flow enhancement without cardiopulmonary depres-
sion. General anesthesia avoids interaction with anticoagulant regimes and 
allows, if required, extension of surgery. Local anesthesia may require sup-
portive sedation and monitoring. 
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  • The use of 2-D ultrasound imaging and guidance is state of the art for vessel 
cannulation and nerve blocks. 
  • Proficiency and teamwork of the providers appear more important than 
anesthesia technique itself, but typical risks and complications need to be 
anticipated. 
 Preoperative Evaluation and Planning 
 Patients requiring vascular access surgery are frequently multimorbid, and sur-
gery is often nonelective. Efficient preoperative planning requires communica-
tion of accurate data, dates and details of schedules and procedures. This in-
cludes planned location and type of vascular access, patient preparation and 
positioning, use of grafts or distal perfusion, etc. 
 Practice guidelines and standard operating procedures of each service should 
be available. Documentation of individual perioperative surgical requirements 
should precede clinical evaluation by anesthesiology.
 Responsibilities for management of chronic and preoperative medication 
need to be clearly defined and communicated between all involved caregivers. 
Timely prescription (e.g. treatment of preoperative anemia), reliable continua-
tion (e.g. beta-blockers, aspirin, statins)  [2] , timely discontinuation (e.g. metfor-
min, platelet inhibitors, new oral anticoagulants), and effective bridging (insu-
lin, unfractionated heparin) of preoperative medications increase patient safety 
by reducing risks of myocardial ischemia, bleeding and transfusion, and help to 
avoid case cancellations.
 Preanesthetic evaluation assesses the patient’s physical status (American So-
ciety of Anesthesiologists ASA PS;  table 1 )  [3] according to relevant active co-
morbidity, medical, surgical and anesthetic history. Results of diagnostic testing 
are reviewed, and a focused physical exam is obtained  [4] . Factors with relevant 
impact on perioperative management are identified.
 The overall aim is to predict a patient’s tolerance to the perioperative stress 
of his/her specific surgical procedure. Whereas peripheral reconstructive vascu-
lar surgery carries a particularly high risk of perioperative cardiac morbidity and 
mortality, peripheral vascular access surgery is classified as low or moderate risk 
surgery.
 Impaired kidney function is a robust indicator of increased perioperative 
risk. Patients with end-stage renal disease (ESRD) requiring vascular access sur-
gery are thus usually ASA class 3 or 4, related to their overall health status. ASA 
classification does not take surgical risk into consideration; this needs to be cat-
egorized separately using appropriate scoring systems  [5] .
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 Preoperative assessment of coronary status and cardiovascular function is 
based on clinical evaluation, noninvasive and invasive diagnostic testing. Physi-
cal performance is evaluated according to simple exercise tasks (e.g. walking up 
stairs), and is quantified by grading their metabolic equivalent (MET,  table 1 ). 
At a performance of 4 MET or more, the patient is usually fit for vascular access 
surgery in locoregional anesthesia (LRA) without further cardiac evaluation  [6] .
 If MET cannot be evaluated, the presence of clinical risk factors (renal dys-
function, ischemic heart disease, congestive heart failure, stroke or TIA, diabetes 
mellitus requiring insulin) is relevant. If up to 2 risk factors are present, nonin-
vasive testing may be considered, but only if it will change management. If 3 or 
more risk factors are present, cardiology consultation and further cardiac testing 
are considered.
 In patients with a cardiac implantable electrical device (CIED), such as an 
internal cardiac pacemaker or defibrillator (ICD), some basic information needs 
to be gathered preoperatively (e.g. indication, current mode of action, underly-
ing cardiac rhythm, type and model of device, accessibility by cardiologist, re-
sponse to magnetic influence, last function control).
 Clinical assessment of pulmonary status is based on history, auscultation and 
noninvasive pulse oximetry/arterial blood gas analysis on room air. Chest radi-
ography and spirometry are indicated only in patients with known or suspected 
significant pulmonary disease. Chronic pleural effusion may require preopera-
tive drainage to support respiratory compensation of renal acidosis, the more so 
if sedation is planned. Current medication regimens should be optimized.
Table 1.  Anesthesiologic risk classification for the determination of perioperative risk and 
quick estimation of physical fitness using MET values [6]
ASA physical status classification
ASA 1 Normal healthy patient
ASA 2 Patient with mild systemic disease
ASA 3 Patient with severe systemic disease
ASA 4 Severe systemic disease that is a constant threat to life
ASA 5 Moribund patient who is not expected to survive without the operation
ASA 6 Declared brain-dead patient (organ donor)
Essential MET values
1 – 3 MET Walking around in the flat, taking care of oneself (eating, getting dressed, 
cleaning)
4 – 6 MET Climbing more than one flight of stairs without stopping, walking >100 m 
on plain ground, easy homework
≥10 MET Sports activities (tennis, swimming, football, skiing)
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 In preexisting severe or acutely exacerbated lung disease, expert pulmonol-
ogy consultation should be obtained. Radiological imaging, body plethysmog-
raphy and CO diffusion capacity are indicated only if results would substantial-
ly influence perioperative management.
 Patients with moderate to severe pulmonary disease requiring vascular access 
surgery will benefit most from a LRA technique. General anesthesia (GA) with 
intermittent positive pressure ventilation (IPPV) and use of muscle relaxants 
impairs respiration more than LRA with maintained spontaneous breathing. 
IPPV may cause dynamic overinflation or barotrauma to lungs, promote atelec-
tasis and impair mucociliary clearance  [7] . This may be associated with in-
creased pulmonary morbidity, prolonged hospital stay, resource utilization and 
cost.
 Questions of specific anesthetic interest in a patient’s history should address 
allergies [e.g. to local anesthetics (LA), antibiotics, disinfectants, radiocontrast, 
protamine]. Previous experiences with general and LRA, the risk of postopera-
tive nausea and vomiting, chronic steroid medication and relevant substance 
abuse should be explored. Substitution therapy may be necessary.
 Proactive patient blood management  implies pre-, intra- and postoperative 
issues. Timely preoperative conventional or noninvasive hemoglobin testing 
should be routine in order to allow anemia workup and treatment. Anemia as-
sociated with ESRD should be treated appropriately in advance of elective sur-
gery. If indicated, hematopoietic stimulation with recombinant erythropoietin 
and concomitant iron substitution should be instituted to avoid or minimize 
perioperative allogeneic transfusion as well as related immunomodulation, in-
fection and cost. This is particularly important in patients awaiting renal trans-
plantation. Nevertheless, type and screen should be available in any patient un-
dergoing vascular access surgery.
 Screening for coagulation disorders or impairment, as well as for active anti-
coagulant and/or antiplatelet medication relies first on history and physical 
exam. Preoperatively, pertinent conditions and medications must be meticu-
lously reviewed. Focused laboratory testing should follow only if indicated (INR, 
aPTT, fibrinogen level, platelet count; platelet function testing; thromboelas-
tometry).
 Adequate orders for discontinuation, bridging or timing of anticoagulants 
must be written to avoid interference with the planned surgery and LRA, but 
also in order to avoid thromboembolic complications  [8] . In patients with re-
cently stented coronaries, mechanical valves or chronic atrial fibrillation, a car-
diology consult should be obtained.
 The most common substances that are suitable in patients with renal insuf-
ficiency are listed in  table 2 , together with pertinent lab tests and recommended 
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discontinuation intervals. The field of anticoagulant and antiplatelet medication 
is evolving rapidly. Practitioners may benefit from guideline-based smartphone 
applications (e.g. CoaguSafe ® for iPhone ® ) to support clinical judgment when 
balancing risks of bleeding and thrombosis.
 Preoperative serum electrolyte status should be known in patients with 
ESRD. Hemodialysis is indicated prior to surgery, if relevant hyperkalemia (6.0 
mEq/l or more) is present, to protect the patient from life-threatening arrhyth-
mia. Severely abnormal serum sodium or chloride needs further workup and 
slow correction. In emergencies, electrolyte correction is initiated without de-
laying life-saving surgery.
 In insulin-dependent diabetics, presurgical fasting and possible delays in the 
OR schedule may complicate blood glucose management, and will require close 
blood glucose and insulin control. Perioperative glucose control is recommend-
ed in the range of 100–180 mg/dl or 5.6–10.0 mmol/l to decrease complications 
(e.g. wound infections) without running risks of hypoglycemia and stroke.
 Patient and nursing team information about smoking, food and drink re-
strictions as well as preoperative medication is mandatory. Smoking should be 
stopped at least 24 h prior to the operation to enhance tracheal clearance. Fasting 
is recommended for a minimum of 6 h prior to anesthesia for food and 2 h for 
clear liquids  [9] .
Table 2.  Widely used anticoagulants and their safe perioperative management [8]
Mode of
action
Antagonist Lab test Substance  Stop prior to Bridging Pause
after 
operation
operat ion single-shot
regional block
GA
COX 1
inhibition
no
specific
platelet
function
test
ASS continue –
stop may
be harmful
continue –
stop may
be harmful
no no no
ADP
receptor
blocker
no
specific
platelet
function
test
clopidogrel
prasugrel
ticagrelor
7 days
7 – 10 days
5 days
7 days
7 – 10 days
5 days
no no no
Xa 
antagonist
no
specific
F Xa
activity
apixaban
rivaroxaban
2 days
1 – 2 days
2 days
1 – 2 days
no heparin no
Vitamin K
antagonist
vitamin K INR coumadin stop assure
INR <1.4
stop assure
INR <1.4
no heparin continue or
bridging
AT III
activator
protamin aPTT/Xa
activity
heparin 4 – 6 h 4– 6 h no no at least 1 h
Prostaglandin
inhibition
no
specific
platelet
aggrega-
tion test
iloprost
prostacyclin
2 h
0.5 h
2 h
0.5 h
no no no
ASS = Acetylsalicylic acid.
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 Pharmacological premedication is usually prescribed for patients with 
planned overnight hospital stay. Low-dose benzodiazepines provide anxiolysis, 
light sedation and anterograde amnesia. Especially at advanced age, benzodiaz-
epines may elicit paradoxical reactions or predispose to postoperative delirium. 
Alternatives for oral premedication are clonidin or haloperidol. Ambulatory pa-
tients usually do not receive preoperative sedatives.
 Preoperative Safety Precautions 
 Good interdisciplinary communication between surgeon and anesthesiologist 
minimizes delays and cancellations in the schedule and helps to prevent or an-
ticipate critical situations. Charts and records should be made accessible to all 
perioperative caregivers. Ideally, they should review scheduled patients together 
in advance. 
 Anesthesia must be clearly informed of surgical positioning, access or can-
nulation sites in order to plan their monitoring and instrumentation. If neces-
sary, postoperative hemodialysis, intermediate or intensive care should be orga-
nized at this time.
 At this point, the decision about the planned anesthesia technique (e.g. GA, 
regional block, local anesthesia with or without sedation) and monitoring must 
be made by the anesthesiologist in accordance with surgical requirements and 
with the patient’s informed consent.
 Throughout the preoperative and preincision periods, a Surgical Safety 
Checklist should be completed according to the standardized, structured three-
tiered ‘Team Time Out’ process recommended by the World Health Organiza-
tion  [10] . All steps are documented in the patient’s record.
 Part 1: Prior to transfer to the OR, the patient is personally identified and the 
surgeon marks the site of surgery. A hospital-wide implemented patient identi-
fication bracelet with patient name, date of birth and identification number en-
sures correct patient verification.
 Part 2: Prior to anesthesia induction, the patient is identified again by name 
and birth date, which are compared with ID bracelet and records. The scheduled 
surgical procedure is confirmed by the patient, and the surgical site marking by 
the OR staff. A brief review of patient’s written informed consent, allergies, fast-
ing interval, airway anatomy, ordered antibiotic prophylaxis, availability of 
blood products and readiness of anesthesia equipment is completed. Specifi-
cally in these patients, preoperative information is verified on correct medica-
tion intake, on fluid restriction orders, the interval since last hemodialysis and 
residual urinary output.
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 Part 3: Immediately prior to incision, the entire OR team performs a team 
time-out. Team members briefly introduce themselves and their role. The sur-
geon explains the procedure; the anesthetist mentions any special concerns. The 
team rehearses conceivable critical situations and their prospective manage-
ment. Antibiotic administration and the availability of special surgical and an-
esthesia equipment are confirmed.
 Special attention in such patients focuses on the presence and function of 
preexisting arteriovenous fistulae, hemodialysis central venous catheters, or ac-
cess for peritoneal dialysis. Arms with vascular accesses are kept free from blood 
pressure cuffs, pulse oximeters, tourniquets and peripheral venous cannulae.
 Gastric emptying is delayed in chronic renal failure  [11] or diabetes, which 
presumptively increases the risk of regurgitation and pulmonary aspiration of 
gastric contents on induction of GA or during deep sedation. pH of gastric se-
cretions can be raised by oral administration of sodium tricitrate (30 ml, 0.3 
mol/l) within 1 h of induction. Also, peritoneal dialysate liquid should be drained 
from the peritoneal cavity prior to OR transfer and induction of anesthesia. If 
GA is planned, precautions for rapid airway control on induction should be 
taken.
 If perioperative antibiotic prophylaxis is indicated, responsibility for drug 
choice, timing and administration must be clear to all. Typical antibiotics for 
perioperative prophylaxis in vascular surgery target bacterial colonization at the 
surgical site, such as cephalosporin (e.g. cefazoline, cefuroxime). To achieve ad-
equate tissue concentration, a time interval between i.v. administration and skin 
incision of 30–60 min is mandatory. The dose of a single shot antibiotic prophy-
laxis is not adapted to renal clearance, but repetition doses may require adapta-
tion.
 Life-threatening allergic responses to medication are rare, with antibiotics, 
relaxants, latex and colloid infusions as the main culprits. Preoperative team 
awareness of known allergies can avoid most major incidents. Minor reactions 
such as skin rash, pruritus or wheals may remain the only manifestation (class 
I), requiring symptomatic treatment only. As first or co-manifestation, life-
threatening symptoms like oropharyngeal swelling, bronchospasm, hypoten-
sion, or shock may ensue (class II–IV). Such symptoms are a clear indication for 
adrenalin (100 μg i.v. bolus), with repetition as needed until the situation im-
proves. In patients without anticoagulation, 0.3–0.5 mg of adrenalin can be giv-
en intramuscularly to provide a continued effect  [12] . Exposure to all suspected 
agents is stopped immediately, 100% oxygen is given, and additional help (re-
suscitation team) is called for.
 LA intoxication from inadvertent intravascular injection or rapid systemic 
absorption of a large LA dose manifests itself by acute changes in CNS function 
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(dysesthesia, drowsiness, tremor, generalized convulsions). This may be fol-
lowed by myocardial depression and bradyasystole or ventricular fibrillation. 
Such incidents require immediate institution of Basic and Advanced Life Sup-
port, and an attempt to attenuate toxic LA action by a trial of Lipid Rescue Ther-
apy (Intralipid ® 20% 1.5 ml/kg i.v., repeatable to a maximum of 8 ml/kg)  [13] . 
Ropivacaine appears less cardiotoxic than bupivacaine and may thus be prefer-
able in patients with cardiovascular comorbidity. Prilocaine can cause signifi-
cant methemoglobinemia, making it a poor choice in an anemia-prone popula-
tion.
 An increasing number of patients present for vascular access surgery carrying 
a CIED (e.g. internal pacemaker, defibrillator ICD, or cardiac resynchronization 
therapy)  [14] . In these patients, the surgeon needs to brief the team ahead of time 
about the use of electrocautery. If monopolar cautery is needed, the pathway of 
the cautery current should be directed far away from the CIED, and the device 
should be reprogrammed or deactivated temporarily. Depending on the device 
and indication, the pacemaker function may be adjusted to a reasonable rate and 
mode of action  [15] .
 Line placement for monitoring and medication in peripheral or central ve-
nous or arterial locations is often challenging. Numerous previous surgeries, 
preexisting fistulae, failed cannulation attempts, hematoma, venous collapse af-
ter hemodialysis, thrombotic vessel occlusion or the presence of CIEDs in cen-
tral veins reduce options and prolong preparation time.
 Frequently, central line or venous dialysis catheter placement under residual 
anticoagulation cannot be avoided. Ultrasound guidance of vessel puncture and 
cannulation facilitates line placement and reduces complication rate (futile 
punctures, hematoma, accidental arterial puncture and injection, nerve dam-
age). Use of ultrasound imaging to guide central venous catheter insertion has 
been recommended as a measure to improve patient safety by national health 
care guideline organizations (www.ahrq.gov 2001; www.nice.org.uk 2002). Cen-
tral venous catheterization (CVC) requires full barrier precautions (mask, cap, 
scrubbing, sterile gown and gloves, sterile equipment handling) to reduce risk of 
CVC-related bloodstream infection.
 Ultrasound guidance for nerve blocks has revolutionized LRA, and has be-
come state of the art (www.nice.org.uk 2009). Precise identification of nerve 
structures minimizes risk of inadvertent vessel injury, intravascular injection 
and complicating hematoma. It improves block success, allows reducing LA 
dose and dose-related toxic effects  [16, 17] .  Table 3 gives an overview of maxi-
mum recommended dose of LA.
 As a consequence, use of ultrasound guidance for anesthesia preparations is 
strongly recommended as an important safety feature in vascular access surgery. 
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Adequate training of ultrasound anatomy and needle navigation skills and ded-
icated equipment should be provided for and maintained by institutions and 
services involved.
 Intraoperative Safety Precautions 
 In vascular access surgery, there is usually a choice between local, locoregional 
or GA. Although anesthesiological considerations apply, the type of anesthesia 
must be suitable for the planned surgery, should be accepted by the surgeon and 
also authorized by the patient with his/her written informed consent. Standard 
operating procedures should be established based on practice guidelines and 
scientific evidence. 
 During any type of anesthesia care, an ECG monitor, pulse oximetry, non-/
invasive blood pressure measurement and a reliable peripheral i.v. access are 
standard. If airway tools are employed, capnography is standard of care to prove 
correct placement of the artificial airway and the presence of respiration, gas ex-
change and circulation  [18] . 
 GA is suitable for all procedures in vascular access surgery patients. Renal 
insufficiency affects clinically relevant pharmacokinetics of some hypnotics, an-
algesics and relaxants.
 Intravenous sedatives and nonopioid hypnotics (midazolam, propofol, 
etomidate, ketamine, dexmedetomidine) undergo mainly hepatic biotransfor-
mation to inactive metabolites. Their prolonged excretion owing to renal insuf-
ficiency is clinically not relevant. Nevertheless, in patients with renal failure a 
Table 3.  Maximum dose of LA for regional nerve blocks in adults 
Type Main metabolism Onset of anesthesia
(depending on
injection site), min
Duration
of action, h
Maximum dosage
Lidocaine amide liver 15 – 30 max. 5 max. 4.5 mg/kg body weight per single 
injection; cumulative dose 300 mg/day
Bupivacaine amide liver > kidney 15 – 30 4 – 6 cumulative dose max. 400 mg/day
Mepivacaine amide liver 15 – 30 1.5 – 2 max. 5 mg/kg body weight per single 
injection; cumulative dose max. 1,000 
mg/day
Ropivacaine amide liver/kidney 10 – 25 6 – 10 max. 250 mg/single injection;
cumulative dose 800 mg/day
 These data are based on Swissmedic information. Recommendations may vary between different countries due to local 
drug regulations. Rescue strategy: lipid rescue therapy can be used intravenously to absorb circulating LA.
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25–50% dose reduction appears advisable due to alterations in blood volume, 
protein binding and pharmacodynamics.
 Clinical pharmacology of synthetic opioid analgesics (fentanyl, sufentanil, 
remifentanil) is not substantially altered by renal failure. In contrast, morphine 
is a poor choice in patients with severe renal impairment, particularly when 
given repetitively. Morphine effects may be prolonged due to very slow elimina-
tion of active metabolites. Postoperative analgesic regimens should also avoid 
nonsteroidal anti-inflammatory drugs.
 Among volatile anesthetics, isoflurane and desflurane are safe for use in pa-
tients with renal impairment and cardiovascular disease. These agents undergo 
minimal (hepatic) metabolism.
 Nondepolarizing muscle relaxants are highly dependent on renal elimination 
if not inactivated otherwise. Degradation pathways of the relaxants atracurium 
or cisatracurium bypass renal function, making them preferable in renal insuf-
ficiency. Rocuronium has an increased elimination half-life in renal failure, but 
its action is swiftly and reliably terminated by i.v. administration of sugamma-
dex.
 Safe induction of GA for vascular access surgery should take specific risk con-
stellations among these patients into account:
 – In chronic renal failure, risks of pulmonary aspiration may be increased due 
to gastroparesis or abdominal distension from residual peritoneal dialysate. 
 – There is a significant risk of marked arterial hypotension, particularly on GA 
induction. Considerate selection and dose reduction of induction anesthetics, 
and titrated use of vasopressor drugs (ephedrine, noradrenaline or phenyl-
ephrine) will mitigate hypotensive episodes and prevent fluid overloading. 
Volemic effects of crystalloid solutions are limited to a short period of time, 
and fluid overloading may be associated with worse outcome  [19] . Artificial 
colloid solutions appear obsolete due to their renal elimination. Alpha-
adrenoceptor agonists should be used conservatively, with the goal to nor-
malize low systemic vascular resistance only. Unnecessary vasoconstriction 
may adversely affect outcome of peripheral vascular surgery. 
 LRA is ever gaining popularity for vascular access surgery due to its sympa-
tholytic and venodilatory effect, overall cardiovascular stability and safety, and 
a potentially positive impact on surgical outcome  [20] . The incidence of vaso-
spasm and early thrombosis may be reduced  [21] . The site of the regional block 
needs to be selected such as to adequately anesthetize the projected vascular ac-
cess site ( table 4 ). For vascular access surgery on the upper extremity, supracla-
vicular, infraclavicular or axillary nerve blocks are typically performed.
 Despite the advantages of LRA, a survey of National Surgical Quality Im-
provement data (NSQIP; 2007–2010) still found a distribution of anesthesia 
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techniques for new arteriovenous fistula creation of 85% GA, 3% local anesthe-
sia with monitored anesthetic care, and only 12% LRA  [22] .
 Compared to GA, an overall better safety profile of LRA has not been proven 
so far. Anesthesia planning in patients with ESRD and typical cardiovascular 
comorbidity must pay close attention to the coagulation system. When coagula-
tion is compromised, regional nerve blocks are associated with a higher neuro-
logical complication rate than GA  [13] . Ultrasound guidance to navigate nerve 
and vessel structures is highly recommended, with the aims to reduce accidental 
vessel injury and amount of LA required  [18] . Still, this will not completely elim-
inate block-induced nerve lesions or hematoma formation.
 Local anesthesia (LA) is a reasonable alternative if patients are compliant and 
cooperative, or when all other anesthesia options are either not applicable or in-
crease risk more than LA. The sympathicolytic effect of LRA and its motor block 
cannot be reproduced using an LA technique. On the other hand, residual anti-
coagulant effects are less of an issue with LA than with LRA. For patients who 
are uncooperative or may become so during surgery (e.g. owing to substance 
dependency, paradoxical reactions, anxiety, delirium), LA is the least preferable 
option.
 Basic monitoring standards apply as mentioned above. Depending on the 
patient’s overall health status, it is advisable to combine surgical LA with moni-
tored anesthesia care (MAC). Intraoperatively, MAC allows the anesthetist to 
diagnose and treat upcoming clinical problems adequately while the surgeon 
can concentrate on his work. When LA is managed without a professional ded-
icated to nonsurgical intraoperative patient care, risks from incomplete or dis-
continuous monitoring and inadequate sedation are inherent. In this field, most 
adverse outcomes arise from respiratory or cardiocirculatory depression. There-
fore emergency equipment, medication and expertise to support or restore vital 
functions should be available in the procedure room, with advanced life support 
expert assistance available within 1–5 min  [23] .
Table 4.  Covered areas of possible LRA procedures
Type of regional block  Area of adequate surgical anesthesia
shoulder  upper arm elbow forearm hand
Interscalene nerve block + + (proximal) – – –
Supraclavicular nerve block – + + + +
Infraclavicular nerve block – + + + +
Axillary nerve block – + (distal) + + +
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 Intraoperative Environment 
 During any operation, the ambient noise level should be minimized such to en-
sure safe communication between OR team members. This reduces distraction 
from their tasks as well as adverse effects (e.g. infections)  [24] . Changes in pa-
tient condition or critical intraprocedural requirements (e.g. call for heparin) 
must be clearly communicated within the team in the closed-loop mode. Any-
body who has important information should be allowed to speak up at any time 
to inform the other team members. 
 The workplace should be organized ergonomically to facilitate the workflow 
of the OR team ( fig. 1 ). Equipment should be arranged such as to allow adequate 
logistics for supplies, give access to the patient without breaking sterility, avoid 
tripwire incidents and cable disconnections, and to allow everybody a view to 
monitors. Urgent interventions should be possible without delay. Emergency 
equipment must be available and accessible at all times.
 Perioperative normothermia avoids excessive sympathetic activation, shiver-
ing, coagulopathy and patient discomfort. Core temperature should be moni-
tored continuously under GA. All patients should be kept normothermic with 
warming OR table mattresses or forced air warming systems. Patients with LRA 
or LA are clinically observed and asked whether they feel comfortable.
 Allogenic blood product transfusion should be unnecessary in vascular ac-
cess surgery with adequate preoperative preparation and surgical technique. 
Transfusion indications should be restrictive and take patients’ preoperative 
chronic stable baseline into consideration. A valid transfusion trigger should 
combine hemoglobin concentration with the presence of clinical indicators of 
critical anemia or risks for critical end-organ ischemia (e.g. coronary or cerebro-
vascular disease  [25–28] ).
 Postoperative Care 
 In the postoperative period, any patient emerging from GA or LRA should be 
observed in a postanesthesia care unit (PACU). Staff must be familiar with typ-
ical anesthesia- and surgery-related complications and postoperative surgical 
treatment. Postanesthetic and surgical orders (e.g. pain management, hemody-
namic targets, antibiotics, anticoagulation, fluid regime, drains and dressings, 
positioning, chronic medication) must be documented in writing and actively 
communicated to PACU staff. Patency and function of a newly established vas-
cular access as well as distal perfusion and sensorimotor function should be con-
trolled regularly by clinical means and Doppler technique. After a regional nerve 
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block, at least the motor block should be regredient prior to discharge from 
PACU. Following GA, patients are released from the recovery area when awake 
and oriented, with vital functions stable, and with pain and postoperative nausea 
and vomiting under control. 
 Critical incident-reporting systems play an important role in identifying er-
rors that are related to structural problems. Institutions can improve patient 
safety in vascular access surgery, as in any perioperative field, by improving OR 
and equipment ergonomics, by collective open-minded learning from each crit-
ical incident  [29] , by supporting training of technical and nontechnical skills 
( fig. 2 ) and critical incident management, and by promoting close interdisciplin-
ary communication and good teamwork behavior  [30] .
Check for
-Equipment
-Emergency
-Help
Time-
out
Preoperative
antibiotics before
skin incision
Monitoring and
defibrillator
Ultrasound guidance for safe vessel
cannulation and regional blocks
Warming system Designation of surgical site
to prevent wrong side
surgery
Patient
identification
bracelet
 Fig. 1. OR setup and equipment for safe anesthesia performance in vascular access
surgery. 
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Decision making
• Identify all options that you have
• Balance risks and select 
 options actively
• Reevaluate the situation
Task management
• Do proper planning and 
 preparation
• Prioritize tasks
• Provide and maintain standards
• Identify and utilize resources
Teamwork
• Coordinate your activities with 
 the team
• Exchange important information 
 continuously
• Use authority and assertiveness 
 appropriately
• Assess capabilities of your team 
 members
• Support others
Situation awareness
• Get information from your 
 surrounding
• Recognize and understand 
 information
• Anticipate possible hazards
P
a t
i e
n
t
6
D
I 
W
\
 Fig. 2. Nontechnical skills that impact patient safety during the perioperative process  [1] . 
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